AU2969899A - Method for treating patients using cellular suspensions of embryonic tissues - Google Patents

Method for treating patients using cellular suspensions of embryonic tissues

Info

Publication number
AU2969899A
AU2969899A AU29698/99A AU2969899A AU2969899A AU 2969899 A AU2969899 A AU 2969899A AU 29698/99 A AU29698/99 A AU 29698/99A AU 2969899 A AU2969899 A AU 2969899A AU 2969899 A AU2969899 A AU 2969899A
Authority
AU
Australia
Prior art keywords
treating patients
embryonic tissues
cellular suspensions
suspensions
cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29698/99A
Inventor
Alexandr Ivanovich Smikodub
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TSENTR EMBRIONALNYKH TKANEI "EMCELL"
Original Assignee
TS EMBRIONALNYKH TKANEI EMCELL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TS EMBRIONALNYKH TKANEI EMCELL filed Critical TS EMBRIONALNYKH TKANEI EMCELL
Publication of AU2969899A publication Critical patent/AU2969899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/54Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/15Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/18Erythrocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/19Platelets; Megacaryocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/407Liver; Hepatocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU29698/99A 1998-12-16 1998-12-16 Method for treating patients using cellular suspensions of embryonic tissues Abandoned AU2969899A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/UA1998/000020 WO2000035464A1 (en) 1998-12-16 1998-12-16 Method for treating patients using cellular suspensions of embryonic tissues

Publications (1)

Publication Number Publication Date
AU2969899A true AU2969899A (en) 2000-07-03

Family

ID=21688710

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29698/99A Abandoned AU2969899A (en) 1998-12-16 1998-12-16 Method for treating patients using cellular suspensions of embryonic tissues

Country Status (3)

Country Link
AU (1) AU2969899A (en)
UA (1) UA64826C2 (en)
WO (1) WO2000035464A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003063883A1 (en) * 2002-01-30 2003-08-07 Airumiyan, Asmik Vardgesovna Mkrtachian embryonal antitumoral modulator, method for the production and use thereof
DK1993575T3 (en) 2006-03-07 2019-10-14 Geeta Shroff COMPOSITIONS INCLUDING HUMAN EMBYO STAM CELLS AND DERIVATIVES THEREOF, METHODS OF USE AND PROCEDURES FOR MANUFACTURING

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2599972B1 (en) * 1986-06-12 1990-06-29 Laumond Gerard EMBRYONIC TISSUE EXTRACTS FROM ANIMAL ORGANS, INJECTABLE TO MAN
SU1711896A1 (en) * 1988-01-28 1992-02-15 Научно-Исследовательский Институт Трансплантологии И Искусственных Органов Method for treating wounds not healing for a long time
UA27048C2 (en) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation
RU95102184A (en) * 1995-02-15 1997-01-20 Научный центр акушерства Method of syndrome treatment after the total ovariectomy
RU95102200A (en) * 1995-02-15 1997-01-20 Научный центр акушерства Method of climacteric syndrome treatment
CA2215143A1 (en) * 1995-03-28 1996-10-03 Thomas Jefferson University Isolated stromal cells and methods of using the same
RU2112525C1 (en) * 1995-07-20 1998-06-10 Институт хирургии Восточно-сибирского научного центра СО РАМН Agent for hyperlipidemia correction
RU2112526C1 (en) * 1996-11-25 1998-06-10 Тамара Михайловна Воробьева Method to treat disorders of central nervous system

Also Published As

Publication number Publication date
UA64826C2 (en) 2004-03-15
WO2000035464A1 (en) 2000-06-22

Similar Documents

Publication Publication Date Title
AU6936800A (en) Method of treating bone for implantation and resulting bone
AU1727400A (en) Apparatus for thermal treatment of tissue
AU2500900A (en) Apparatus and methods for treating congestive heart disease
HU0001471D0 (en) New method of treatment
AU3784999A (en) Methods for treatment of pain
AU2105399A (en) Method of preparing treated silica
HUP0200738A3 (en) Method of the treatment of incontinence
AU4552200A (en) Method of treating psychotic disorders
AU6883398A (en) Methods of treating bone loss
AU2969899A (en) Method for treating patients using cellular suspensions of embryonic tissues
AU4598400A (en) Method of treatment
AU2382601A (en) Novel method of treatment
GB9824893D0 (en) Novel method of treatment
AU1784701A (en) Method of treating neuroblastoma
AU6037499A (en) Methods of treating viral disease
AU4914600A (en) Method for treating tnf-receptor type-2-induced diseases
AU4005599A (en) Method for diagnosis and treatment of cancer
AU1353901A (en) Method of treating batten disease
AU2270100A (en) Method for the treatment of bone loss
AU8857298A (en) Method for prophylaxis or treatment of bone density loss
AU6240999A (en) Laminin 5 for treatment of bone defects
AUPP584798A0 (en) Method of treatment
AUPP460798A0 (en) Method of treatment
AUPP795298A0 (en) Method of treatment
AUPP363398A0 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase